Institute Of Eye Surgery Limited
- Address
- lock Available on a paid plan
Ophthalmology and Eye Diseases
The Institute Of Eye Surgery Limited in Waterford is conducting clinical research in ophthalmology focused on improving care for serious retinal conditions. The trials center on age-related macular degeneration and related complications, with the aim of evaluating new approaches that may help preserve vision and slow disease progression.
- Research in exudative age-related macular degeneration and treatment options for submacular haemorrhage
- Studies assessing the effectiveness of new eye treatments compared with current standard care
This work reflects a strong focus on retinal disease management, combining efforts to test potential therapies and better understand how to improve outcomes for patients with advanced macular disease.
Retinal Therapy Research in Waterford
A smaller but focused trial portfolio at this hospital/clinic is exploring treatment strategies for conditions linked to vision loss from retinal degeneration. The research includes efforts to evaluate whether new ophthalmic therapies can reduce lesion growth and support better long-term visual health.
- Investigation of non-foveal geographic atrophy secondary to non-neovascular age-related macular degeneration
- Evaluation of a potential new ophthalmic solution for slowing disease progression
Overall, the site’s studies are aimed at advancing both treatment effectiveness and disease control in major retinal disorders, with a clear emphasis on practical benefits for patients affected by progressive eye disease.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 3 by active trials.
- 1Galimedix Therapeutics Inc.1active
lock +2 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 45 other sites in Ireland
Therapeutic Area Benchmark — Ireland
Select a therapeutic area to compare against other sites in Ireland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Ireland
Market Share
Country: Ireland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Institute Of Eye Surgery Limited
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| A Phase 3b Study to Evaluate the Duration of Effect of Bimatoprost SR in Participants with Open-Angle Glaucoma or Ocular Hypertension | AbbVie Deutschland GmbH & Co. KG | Phase III | Not Recruiting | Aug 2019 | Jul 2025 |
IMP list
lock Showing 1 of 4 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Aflibercept | 1 | Unknown | 2024-09-24 | 2024-09-24 |
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.